Servier Ventures
Status
ACTIVE
Global HQ
Paris, France
Countries of investment
- United States
- France
- United Kingdom
- Germany
Investment stages
- Seed
- Series A
Industries
- Healthcare
- Biotech
About
Servier Ventures is the corporate venture capital arm of the global pharmaceutical group Servier. Its mission is to identify and finance promising innovations in biotechnology and medical technology that align with the Group's strategic priorities. The fund acts as a strategic partner to accelerate the development of new therapies for patients.
Servier Ventures is the corporate venture capital arm of the global pharmaceutical group Servier. Its mission is to identify and finance promising innovations in biotechnology and medical technology that align with the Group's strategic priorities. The fund acts as a strategic partner to accelerate the development of new therapies for patients.
Investment Thesis
Servier Ventures is a strategic corporate venture fund investing in innovative biotech and medtech companies. The fund focuses on Servier’s strategic therapeutic areas, including oncology, immuno-inflammation, neuroscience, and cardiometabolism. It invests from early-stage (seed and Series A) to later stages, taking an active role in governance by sitting on the Board of Directors to help accelerate the development of therapeutic solutions.
Manager's Experience
Servier Ventures is led by experienced life-science and corporate innovation executives within Servier Group, a global pharmaceutical company. The team blends deep scientific R&D leadership with strategic investment capability, leveraging the firm’s heritage in oncology and neurology research. They focus on early access to breakthrough biotech innovation, drawing on Servier’s scientific expertise and global operational scale to support emerging companies with both capital and domain insight.
Team
David Garmey - Head of Servier Ventures (Boston)
François-Xavier de Saint-Hilaire - (Paris)